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The mitotic checkpoint protein hsMad2 is required to arrest cells
in mitosis when chromosomes are unattached to the mitotic
spindle1. The presence of a single, lagging chromosome is suf®-
cient to activate the checkpoint, producing a delay at the
metaphase±anaphase transition until the last spindle attachment
is made2. Complete loss of the mitotic checkpoint results in
embryonic lethality owing to chromosome mis-segregation in
various organisms3±6. Whether partial loss of checkpoint control
leads to more subtle rates of chromosome instability compatible
with cell viability remains unknown. Here we report that deletion
of one MAD2 allele results in a defective mitotic checkpoint in
both human cancer cells and murine primary embryonic ®bro-
blasts. Checkpoint-defective cells show premature sister-chroma-
tid separation in the presence of spindle inhibitors and an elevated
rate of chromosome mis-segregation events in the absence of
these agents. Furthermore, Mad2+/- mice develop lung tumours at
high rates after long latencies, implicating defects in the mitotic
checkpoint in tumorigenesis.
Genetic instability in cancers occurs frequently with whole
chromosomes, referred to as chromosome instability (CIN)7. CIN
cells become aneuploid (that is, they acquire abnormal chromo-
some numbers), a hallmark of cancer that is associated with
aggressive tumour behaviour and a poor prognosis8. Aneuploidy
may facilitate tumorigenesis or tumour progression through the
loss of tumour-suppressor gene function. The mechanisms respon-
sible for the development of aneuploidy in cancers remain unclear.
Defects in the mitotic checkpoint have been correlated with CIN in
human cancer cells but have not yet been shown to be a direct cause
of the CIN phenotype9. We therefore investigated whether the loss of
MAD2 through targeted deletion in a cancer cell line that is
chromosomally stable would result in its transformation into a
CIN line. We chose the Hct-116 human colon carcinoma cell line
because it has a normal mitotic checkpoint and is amenable to gene
targeting9±11.
We generated two independent Hct-MAD2+/- clones for analysis
(For details of the vector design and genomic analysis, see Supple-
mentary Information). We exposed asynchronous Hct-MAD2+/-
cells to nocodazole and then measured the mitotic index by staining
them with MPM-2, a mitosis-speci®c antigen. Sixty per cent of
wild-type cells arrest by 18 h, whereas only 10% of mutant cells do so
(Fig. 1a). Consistent with the loss of the mitotic checkpoint, 77% of
mutant cells proceed into a subsequent S phase, as assayed by DNA
content, compared with 36% of wild-type cells (Fig. 1b). The
checkpoint defect of MAD2+/- cells was con®rmed by assaying
cyclin-B-associated Cdc2 kinase activity of G1/S synchronized cell
populations that had been released into nocodazole. Wild-type cells
show high levels of Cdc2 kinase activity for 24 h, whereas the kinase
activity of mutant cells falls rapidly after 12 h in nocodazole (Fig. 1c,
d). This fall in kinase activity is accompanied by the acquisition of
8N DNA content (where N is the amount of DNA in a haploid cell),
as mutant cells proceed through the next cell cycle (Fig. 1e). After
24 h, most of the wild-type cells have rounded up and detached
from the culture dish, whereas mutant cells remain adherent as they
continue to cycle (Fig. 1f, g). On prolonged exposure to nocodazole
(over 48 h), mutant cells become multinucleated with a polyploid
DNA content (Fig. 1h).
To ensure that the phenotype observed in Hct-MAD2+/- cells was
not the result of the transfection or selection process, two selected
clones that had not recombined homologously were challenged
with nocodazole and found by MPM-2 staining to arrest in mitosis
identically to Hct-116 non-transfected controls (data not shown).
Immunoblots against MAD2 with polyclonal anti-sera show one
species with a relative molecular mass of 27,000 (Mr 27K) in both
Hct-MAD2+/- clones, indicating that there is not a dominant-
negative effect of a partial protein product. Quantitative iodinated
immunoblots normalized to Cdk2 show that Hct-MAD2+/- cells
express 70% of the amount of MAD2 protein expressed in wild-type
cells, suggesting partial compensation of protein levels in the
absence of one allele (see Fig. 2, Supplementary Information,).
We found that the expressed allele is wild type by polymerase chain
reaction with reverse transcription of RNA and subsequent
sequence analysis. Finally, the checkpoint status of ten independent
subclones derived from the Hct-116 parental line was analysed and
determined to be normal, which excludes clonal variation as the
cause of the checkpoint defect in Hct-MAD2+/- clones (data not
shown).
MAD2 arrests cells in metaphase by associating with the ana-
phase-promoting complex (APC), thereby inhibiting its ubiquitin
ligase activity12±14. On release from the checkpoint, progression into
anaphase and sister-chromatid separation requires APCCdc20-
dependent degradation of Pds1, or securin15,16. Checkpoint-chal-
lenged mutant cells containing catalytically active APC are expected
to degrade securin prematurely; indeed, after release from a double
thymidine block into nocodazole, Hct-MAD2+/- cells fail to accu-
mulate the high levels of securin seen in wild-type cells (Fig. 2a). As
the mutant cells exit mitosis, the observed loss of Cdc2 activity is not
accompanied by a concomitant decrease in cyclin B protein levels
(data not shown). As phosphorylation of CDC28 in yeast is a
potential mechanism of mitotic exit in checkpoint-challenged
cells17 (see also ref. 18), we performed immunoblots using antisera
speci®c for phosphorylated forms of Tyr 15 on Cdc2 . We observed
no increases in Tyr 15 phosphorylation, nor were we able to detect
by co-immunoprecipitation any signi®cant decreases in cyclin-B-
associated Cdc2 protein levels between 12 and 16 h when the decline
in kinase activity is most pronounced (Fig. 2b and data not shown).
Further studies are required to determine the precise mechanism of
mitotic exit in checkpoint-challenged mammalian cells.
Sister chromatids that have separated prematurely are a hallmark
of a defective mitotic checkpoint and have been observed in yeast
mad2 mutants and Drosophila bub1 mutants3,16,19. Therefore, we
looked for evidence of precocious anaphase in checkpoint-de®cient
cells by preparation of metaphase spreads in the presence of
colcemid, a spindle inhibitor. Roughly 20% of mitotic ®gures
from the Hct-MAD2+/- cells showed prematurely separated sister
chromatids, compared with 1% in wild-type cells (Fig. 3a±d).
We performed chromosome counts on metaphase spreads to test
the importance of the mitotic checkpoint on chromosome stability.
Hct-MAD2+/- cells showed an 80% increase in the frequency of
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aneuploid metaphases relative to wild-type Hct-116 cells, which
have a relatively stable (45,X) karyotype (Fig. 3e). We did not
perform karyotype analysis on cells containing 45 chromosomes,
which possibly resulted in an underestimation of the total number
of mis-segregation events. Using interphase ¯uorescence in situ
hybridization (FISH) with chromosome-speci®c anti-centromeric
probes for several chromosomes statistically signi®cant differences
in chromosome numbers (P , 0.008 to P , 0.00001, by Fisher exact
test) were identi®ed between wild-type and Hct-MAD2+/- cells
(Fig. 4a, b). We did not identify differences for chromosome 17
(data not shown). The mechanism of chromosome mis-segregation
in checkpoint-defective Hct-MAD2+/- cells may be due to prema-
ture anaphase even in the absence of spindle inhibitors, but other
molecular explanations are possible.
We measured the rates of chromosome loss on clonal populations
to determine whether Hct-MAD2+/- cells possess a perpetual CIN
phenotype, or whether they have acquired an abnormal karyotype
as a result of rare events propagated in subsequent generations. We
performed chromosome counts on two independently derived
wild-type and four Hct-MAD2+/- clones after 25 generations. We
observed a roughly 100% increase in the rate of chromosome losses in
Hct-MAD2+/- cells (Fig. 4c). Notably, one of the mutant clones,
which has high rates of chromosome instability, has a modal
karyotype of 47 chromosomes, possibly re¯ecting the high degree
of karyotypic heterogeneity in the parental Hct-MAD2+/- population.
To determine whether the haplo-insuf®cient effect seen in trans-
formed cells also occurs in primary cells, we studied metaphase
spreads from murine embryonic ®broblasts (MEFs) derived from
the Mad2+/- mouse5. MEFs from four out of ®ve Mad2+/- mice
showed high frequencies of premature sister-chromatid separation
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Figure 1 Hct-MAD2+/-cells have a mitotic checkpoint defect. a, b, FACS pro®le of
unsynchronized human Hct-116 and Hct-MAD2+/-cells treated with nocodazole and
stained with MPM-2 (a) and with propidium iodide (b). c, Cyclin-B-associated Cdc2 kinase
activity on histone H1 substrate of Hct-116 versus Hct-MAD2+/-cells synchronized in
G1/S by double thymidine block and then released into nocodazole. d, Cyclin-B-
associated Cdc2 kinase activity from the same time course. e, FACS pro®le of propidium-
iodide-stained cells from the same time course. The 42-h time point is not shown because
of its similarity to the 36-h time point. f, DIC microscopy images of unsynchronized
Hct-116 cells exposed to nocodazole for 24 h showing an almost complete absence of
adherent cells. g, DIC microscopy images of Hct-MAD2+/-cells that remain attached to the
tissue-culture dish after treatment for 24 h. Arrows show adherent cells. h, Hct-MAD2+/-
cells exposed to nocodazole for 52 h and analysed by DAPI staining and
immuno¯uorescence microscopy become multinucleated. Magni®cation of f±h ´ 1,000.
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relative to wild-type control cultures (Table 1; see also Supplemen-
tary Information). We performed chromosome counts on three of
the four MEF Mad2+/- cultures and in all cases there was a
signi®cant increase in the number of aneuploid cells relative to
the controls (Table 1). The percentage of aneuploid cells correlates
with the severity of premature sister-chromatid separation, suggest-
ing a direct relationship between the severity of loss of checkpoint
control and chromosome mis-segregation (Table 1). We note that
Mad2+/- mice develop normally, and blastocysts from Mad2 hetero-
zygote animals display no evidence of an impaired checkpoint as
assayed by reactivity to phospho-histone 3 antibody, but premature
sister-chromatid separation was not examined in these
experiments5.
Importantly, a high frequency of papillary lung adenocarcino-
mas, an extremely rare tumour in most wild-type mouse strains, is
identi®able in Mad2+/- mice killed between 18 and 19 months of
age, which suggests a role for defects in the mitotic checkpoint in
tumorigenesis (Table 2)20. The background rate of lymphomas seen
in ageing mice is unchanged in the heterozygote mice. Why the lung
is particularly affected by loss of mitotic checkpoint control, the
cause of the latency and the rate of chromosome mis-segregation in
these tumours are currently being investigated, and the results are
likely to clarify the role of mitotic checkpoints in tumour initiation
and progression.
The molecular basis of the CIN phenotype has, until recently,
remained obscure21,22. Our results indicate that partial loss of the
mitotic checkpoint may not only be a direct cause of chromosome
instability, but may also contribute to tumorigenesis. Defects in the
mitotic checkpoint are common in human cancer and have been
identi®ed in colon, lung and breast cancer cell lines1. Although
MAD2 mutations have not been detected in colon and lung cancer
cell lines with mitotic checkpoint defects23,24, we show here that
subtle differences in MAD2 protein levels markedly alter checkpoint
function. Therefore, inactivation of one MAD2 allele, either by
letters to nature
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Figure 2 Inappropriate degradation of securin in Hct-MAD2+/- cells. a, Immunoblot
analysis of total cellular protein extract obtained over 24 h from Hct-116 and Hct-MAD2+/-
cells synchronized by double thymidine block in G1/S and released into nocodazole.
b, Cyclin-B-associated Cdc2 kinase activity on histone H1 from the same time course.
Synchronization and progression through the cell cycle was con®rmed by FACS of





































Figure 3 Karyotype analysis of genomic instability in Hct-MAD2+/- cell lines. a, Normal G-
banded metaphase spread from Hct-116 cell lines. b, Premature sister-chromatid
separation from one Hct-MAD2+/- cell line. Brackets show sister chromatids lying
separated and adjacent to one another. All of the sister-chromatid pairs are prematurely
separated in mitotic ®gures that show this phenotype. FISH analysis using chromosome-
speci®c FISH probes for CEP 12 (red), CEP 16 (red) and CEP 7 (green), on mitotic ®gures
from the Hct-116 cell line (c) and Hct-MAD2+/- cell line (d). Magni®cation of c and d,
´ 1,000. Arrows indicate a prematurely separated sister-chromatid pair with a third
chromatid lying between the two. e, Distribution of chromosome numbers of Hct-116 and
two Hct-MAD2+/- cell lines. At least 400 metaphases were counted for each cell line.
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epigenetic silencing or deletion, would be suf®cient to create a
haplo-insuf®cient effect and the loss of mitotic checkpoint control.
Of note, loss of heterozygosity around 4q27, to which MAD2 has
been mapped, has been identi®ed in several different tumour
types25±28.
Our results also provide a new cytogenetic marker (premature
sister-chromatid separation) that should guide screening efforts for
the identi®cation of mitotic checkpoint defects in primary tumour
samples. Preliminary analysis in primary human cancers has iden-
ti®ed such defects (A.C. and V.V.V.S.M., unpublished observations),
but further investigation is needed as to whether these are due to
subtle decreases in MAD2 levels, or other components of the spindle
assembly checkpoint. The precise involvement that a partial loss of
mitotic checkpoint function has in the development, progression
and management of cancer remains to be determined. As MAD2+/-
cells become highly aneuploid and continue to cycle after prolonged
exposure to spindle inhibitors, checkpoint-defective tumours may
be more aggressive and resistant to anti-mitotic chemotherapeutics.
FurthermoreÐand more fundamentallyÐthe long latency period
essential for tumour formation in the Mad2+/- mice suggests that
cooperative mutations at additional oncogenic or tumour-suppres-
sor loci are required to drive transformation in checkpoint-defective
cells. Further analysis of the Mad2+/- mice should identify these
putative genetic interactions. M
Methods
Cell-cycle analysis and Cdc2 kinase assays
We placed asynchronous cells in 200 ng ml-1 nocodazole, and then ®xed in 70% ethanol at
the given time points. Cells were stained with anti-MPM-2 mouse monoclonal antibody
(Upstate Biotechnology), washed and stained with goat anti-mouse ¯uorescein isothio-
cyanate (Sigma) and propidium iodide. We performed cell synchronization and H1 kinase
assays as described14. Detached cell populations were collected and combined with
adherent cells for all experiments.
Protein and immunoblot analysis
We prepared total cellular protein extracts as described14. For securin, cyclin B and anti-
Tyr 15 Cdc2 immunoblots, 30 mg of total cellular extract was resolved by SDS±poly-
acrylamide gel electrophoresis, transferred to nitrocellulose, and probed with rabbit anti-
securin polyconal antibodies, rabbit anti-cyclin B polyclonal antisera, (Santa Cruz), or
phospho-speci®c anti-Cdc2 (Tyr 15) rabbit polyclonal antibodies (New England Biolabs).
Horseradish-peroxidase were conjugated donkey anti-rabbit antisera (Amersham) used
as secondary antibody, and immunodetection was accomplished by enhanced chemi-
luminescence (Amersham).
Methods for karyotype, FISH and microscopy
We performed metaphase spreads and Giemsa staining as described29. We carried out FISH
using chromosome-speci®c centromeric probes obtained from Vysis, in accordance with
the manufacturer's protocol. We analysed slides stained with DAPI counterstain with a
Nikon Eclipse 600 microscope attached to an applied imaging cytovision imaging system.
We obtained mouse embryonic ®broblasts from 13.5-day-old embryos and used them at
passage 3 for metaphase spread preparation as above. For DIC and immuno¯uorescence
microscopy, live cells or cells ®xed with 2% paraformaldehyde and stained with 1 mg ml-1
DAPI were visualized with an Axiovert 100M microscope (Zeiss) using DIC imaging.
Animal breeding and tumour analysis
Mad2+/- mice were screened and identi®ed as described5. Tissues were collected, ®xed in
formalin and embedded in paraf®n blocks before staining with haematoxylin and eosin,
and microscopic analysis.
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Figure 4 Interphase FISH analysis using chromosome-speci®c FISH probes on Hct-116
and Hct-MAD2+/- cells. a, Summary of six different experiments. 400±600 cells were
scored for aneuploidy for each cell line. NS; not signi®cant. b, Microscopy image of
interphase FISH on Hct-MAD2+/- cells using probes for chromosomes 7 (green) and 8 (red)
showing three normal and three aneuploid cells. Magni®cation ´ 1,000.
c, Chromosome counts from metaphase spreads on cell populations derived from single
cell Hct-116 and Hct-MAD2+/- clones after 25 generations. Roughly 100 metaphases
were counted for each cell line.








Mad2+/+ 7 16 (n = 102)
Mad2+/- 30 40 (n = 42)
Mad2+/- 36 57 (n = 60)
Mad2+/- 57 75 (n = 33)
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Table 2 Tumour frequency in ageing mice
Lymphomas Lung tumours
.............................................................................................................................................................................
Mad2+/+ 7.4% (2/27) 0% (0/27)
Mad2+/- 9.8% (5/51) 27.5% (14/51)
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Wild-type and Mad2+/- mice were killed at the age of 18±19 months.
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Meiosis is initiated from G1 of the cell cycle and is characterized
by a pre-meiotic S phase followed by two successive nuclear
divisions. The ®rst of these, meiosis I, differs from mitosis in
having a reductional pattern of chromosome segregation1,2. Here
we show that meiosis can be initiated from G2 in ®ssion yeast cells
by ectopically activating the meiosis-inducing network. The sub-
sequent meiosis I occurs without a pre-meiotic S phase and with
decreased recombination, and exhibits a mitotic pattern of equa-
tional chromosome segregation. The subsequent meiosis II results
in random chromosome segregation. This behaviour is similar to
that observed in cells lacking the meiotic cohesin Rec8 (refs 3, 4),
which becomes associated with chromosomes at G1/S phase,
including the inner centromere, a region that is probably critical
for sister-centromere orientation5. If the expression of Rec8 is
delayed to S phase/G2, then the centromeres behave equationally.
We propose that the presence of Rec8 in chromatin is required at
the pre-meiotic S phase to construct centromeres that behave
reductionally and chromosome arms capable of a high level of
recombination, and that this explains why meiosis is initiated
from G1 of the cell cycle.
The meiosis-inducing regulatory network is well characterized in
®ssion yeast6±9. We have found that this network is activated only at
G1, which explains why meiosis is initiated only during this phase of
the cell cycle (see Supplementary Information). On the basis of
these ®ndings, we have developed a method of inducing synchro-
nous meiosis from G2 (G2-exit meiosis) by ectopically activating
the meiosis-inducing regulatory network during G2 (see Methods),
and have compared G2-exit meiosis with meiosis induced from G1
(G1-exit meiosis) (Fig. 1). The cells entering meiosis from G1
underwent a pre-meiotic S phase, meiotic nuclear divisions and
sporulation as expected. By contrast, the cells entering meiosis
from G2, after mitotic S phase, failed to undergo DNA replication,
but did undergo meiotic nuclear divisions and sporulation
(Fig. 1a, b, d).
To characterize G2-exit meiosis, we ®rst monitored spindle pole
bodies and showed that they remained unseparated until 4 h,
indicating that, as in G1-exit meiosis, the spindle was not formed
until just before meiosis I (Fig. 1b, and data not shown). Second, we
induced meiosis from G2 in mei4¢ mutant. The mei4 gene is
required speci®cally for meiosis I but is not required for mitosis10.
The mei4¢ cells undergoing G2-exit meiosis all arrested with a
single nucleus, establishing that the nuclear divisions were meiotic
in character rather than mitotic (data not shown). Third, we
examined transcripts of the meiosis-speci®c genes rec12, rec6,
rec8, spo5, mei4 and spo6, and found that all were induced during
both G1-exit and G2-exit meioses (Fig. 1c). Two genes required for
DNA replication, cdc18 and cdc22, were induced only during G1-
exit meiosis (Fig. 1c), which was consistent with the fact that G2-exit
meiotic cells do not undergo a pre-meiotic S phase. Thus, the
normal meiotic transcriptional programme is activated during G2-
exit meiosis. Last, we assessed intragenic recombination levels by
using two closely linked ade6 mutations11. Recombination levels
during G1-exit meiosis were similar to those observed during a
normal physiological meiosis, but were 20-fold higher than those
observed during G2-exit meiosis. The latter level was similar to,
although somewhat higher than, the recombination level observed
during a mitotic cell cycle. Measurement of intergenic recombina-
tion between lys1 and leu2 yielded similar results (see Supplemen-
tary Information). We conclude that G2-exit meiosis shows several
characteristics of a normal meiosis, although recombination levels
are lower.
We next investigated chromosome segregation. The cdc2ts muta-
tion blocks meiosis II, leading to the generation of dyads containing
two spores12, but the cdc2ts allele does not impair meiotic recombi-
nation or reductional division at meiosis I (ref. 4, and data not
shown). The cessation of meiosis before the second division allows
us to distinguish between reductional and equational chromosome
segregation during meiosis I (ref. 4). Spores from dyads showed
over 80% viability in both G1-exit and G2-exit meioses, but spores
from tetrads were only 14% viable in G2-exit meiosis in comparison
with 86% viable in G1-exit meiosis (Fig. 1e). Staining of nuclei in
G2-exit meiosis with 4,6-diamidino-2-phenylindole (DAPI) indi-
cated that chromosome segregation was equal during meiosis I but
unequal during meiosis II (Fig. 1d). To assess whether meiosis I was
reductional or equational, the segregation of two centromere-linked
markers, lys1 and ade6, was monitored in dyads. In G1-exit meiosis,
segregation was predominantly +/+, -/-, which was indicative of
reductional segregation (Fig. 1f). The occurrence of some +/-, +/-
dyads can be explained by recombination between the markers and
the centromeres; recombination in the dyads would be expected to
be 8% with lys1 maker (4 cM from the centromere of chromo-
some I) and 32% with ade6 maker (16 cM from the centromere of
chromosome III). In contrast, segregation during G2-exit meiosis
was entirely equational, as indicated by the presence of exclusively
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